Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Balicatib (AAE581) is a potent and selective inhibitor of cathepsin K, used in trials studying the treatment of osteoporosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 35.00 | |
5 mg | In stock | $ 56.00 | |
10 mg | In stock | $ 101.00 | |
25 mg | In stock | $ 235.00 | |
50 mg | In stock | $ 441.00 | |
100 mg | In stock | $ 636.00 | |
500 mg | In stock | $ 1,330.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 62.00 |
Description | Balicatib (AAE581) is a potent and selective inhibitor of cathepsin K, used in trials studying the treatment of osteoporosis. |
Kinase Assay | Cell-free kinase activity assays: Glutathione-S-transferase (GST)-tagged JAK kinase domains expressed in insect cells are purified before use in a peptide substrate phosphorylation assay. Assays are carried out in 384-well optiplates using an Alphascreen Protein Tyrosine Kinase P100 detection kit and a PerkinElmer Fusion Alpha instrument. |
Synonyms | AAE581 |
Molecular Weight | 411.54 |
Formula | C23H33N5O2 |
CAS No. | 354813-19-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (121.49 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Balicatib 354813-19-7 Proteases/Proteasome Cysteine Protease AAE581 AAE 581 osteoporosis inhibit AAE-581 Inhibitor bone formation dermal fibroblasts Cathepsin bone turnover inhibitor